InterNex Capital provided a $1.5 million line of credit to a Maryland-based company that assists organizations in bringing drug treatments to the market through health research services.
The company sought a liquidity solution to enhance working capital and fund growth.
The line of credit will support the company’s short-term working capital needs as well as future growth to support its sales to both private and federal government customers.
